» Articles » PMID: 30932177

Stimulation of β-adrenoceptors Up-regulates Cardiac Expression of Galectin-3 and BIM Through the Hippo Signalling Pathway

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2019 Apr 2
PMID 30932177
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Expression of the pro-fibrotic galectin-3 and the pro-apoptotic BIM is elevated in diseased heart or after β-adrenoceptor stimulation, but the underlying mechanisms are unclear. This question was addressed in the present study.

Experimental Approach: Wild-type mice and mice with cardiac transgenic expression of β -adrenoceptors, mammalian sterile-20 like kinase 1 (Mst1) or dominant-negative Mst1, and non-specific galectin-3 knockout mice were used. Effects of the β-adrenoceptor agonist isoprenaline or β-adrenoceptor antagonists were studied. Rat cardiomyoblasts (H9c2) were used for mechanistic exploration. Biochemical assays were performed.

Key Results: Isoprenaline treatment up-regulated expression of galectin-3 and BIM, and this was inhibited by non-selective or selective β-adrenoceptor antagonists (by 60-70%). Cardiac expression of galectin-3 and BIM was increased in β -adrenoceptor transgenic mice. Isoprenaline-induced up-regulation of galectin-3 and BIM was attenuated by Mst1 inactivation, but isoprenaline-induced galectin-3 expression was exaggerated by transgenic Mst1 activation. Pharmacological or genetic activation of β-adrenoceptors induced Mst1 expression and yes-associated protein (YAP) phosphorylation. YAP hyper-phosphorylation was also evident in Mst1 transgenic hearts with up-regulated expression of galectin-3 (40-fold) and BIM as well as up-regulation of many YAP-target genes by RNA sequencing. In H9c2 cells, isoprenaline induced YAP phosphorylation and expression of galectin-3 and BIM, effects simulated by forskolin but abolished by PKA inhibitors, and YAP knockdown induced expression of galectin-3 and BIM.

Conclusions And Implications: Stimulation of cardiac β-adrenoceptors activated the Mst1/Hippo pathway leading to YAP hyper-phosphorylation with enhanced expression of galectin-3 and BIM. This signalling pathway would have therapeutic potential.

Linked Articles: This article is part of a themed section on Adrenoceptors-New Roles for Old Players. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.14/issuetoc.

Citing Articles

YAP-mediated GPER signaling impedes proliferation and survival of prostate epithelium in benign prostatic hyperplasia.

Liu Z, Li S, Chen S, Sheng J, Li Z, Lv T iScience. 2024; 27(3):109125.

PMID: 38420594 PMC: 10901089. DOI: 10.1016/j.isci.2024.109125.


Unraveling the role of galectin-3 in cardiac pathology and physiology.

Seropian I, Cassaglia P, Miksztowicz V, Gonzalez G Front Physiol. 2024; 14:1304735.

PMID: 38170009 PMC: 10759241. DOI: 10.3389/fphys.2023.1304735.


Sympatho-adrenergic mechanisms in heart failure: new insights into pathophysiology.

Du X Med Rev (2021). 2023; 1(1):47-77.

PMID: 37724075 PMC: 10388789. DOI: 10.1515/mr-2021-0007.


The Role of Galectin-3 in Heart Failure-The Diagnostic, Prognostic and Therapeutic Potential-Where Do We Stand?.

Zaborska B, Sikora-Frac M, Smarz K, Pilichowska-Paszkiet E, Budaj A, Sitkiewicz D Int J Mol Sci. 2023; 24(17).

PMID: 37685918 PMC: 10488150. DOI: 10.3390/ijms241713111.


The hippo kinases MST1/2 in cardiovascular and metabolic diseases: A promising therapeutic target option for pharmacotherapy.

Yin Y, Tan M, Han L, Zhang L, Zhang Y, Zhang J Acta Pharm Sin B. 2023; 13(5):1956-1975.

PMID: 37250161 PMC: 10213817. DOI: 10.1016/j.apsb.2023.01.015.


References
1.
Wang J, Liu S, Heallen T, Martin J . The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration. Nat Rev Cardiol. 2018; 15(11):672-684. DOI: 10.1038/s41569-018-0063-3. View

2.
Cohn J, Levine T, Olivari M, Garberg V, Lura D, Francis G . Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311(13):819-23. DOI: 10.1056/NEJM198409273111303. View

3.
Peter P, Brady J, Yan L, Chen W, Engelhardt S, Wang Y . Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor. J Clin Invest. 2007; 117(5):1335-43. PMC: 1849986. DOI: 10.1172/JCI29576. View

4.
Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol. 2010; 160(7):1577-9. PMC: 2936830. DOI: 10.1111/j.1476-5381.2010.00872.x. View

5.
Nguyen M, Kiriazis H, Ruggiero D, Gao X, Su Y, Jian A . Spontaneous ventricular tachyarrhythmias in β2-adrenoceptor transgenic mice in relation to cardiac interstitial fibrosis. Am J Physiol Heart Circ Physiol. 2015; 309(5):H946-57. DOI: 10.1152/ajpheart.00405.2015. View